Patient information
General information for patients and carers about medical cannabis: what it is, how it is prescribed in the Czech Republic, and how to find a pharmacy.
motagon.euCrawled Nov 16, 2026
General information for patients and carers about medical cannabis: what it is, how it is prescribed in the Czech Republic, and how to find a pharmacy.
What the cannabis plant contains, how it interacts with the body, what research has established, and who can prescribe it in the Czech Republic.
How Czech pharmacies order Motagon medical cannabis products through their wholesaler, become a partner pharmacy, and receive an email for every batch released.
General information for patients and caregivers about medical cannabis: what it is, how it is prescribed in the Czech Republic, and how to find a pharmacy.
Mota is Motagon's own EU-GMP medical cannabis range: ROSE for THC-dominant and SILVER for balanced THC/CBD profiles, non-irradiated throughout.
Motagon takes other producers' medical cannabis brands to market in the Czech Republic, and is the exclusive Czech distributor for Curaleaf.
What the published literature shows on medical cannabis in chronic pain, including negative findings, opioid-sparing data and cytochrome P450 interactions.
Why chronic pain is difficult to treat, how cannabis is used alongside other analgesics, and the conditions in which it is most commonly prescribed.
The page explains how the endocannabinoid system works, the effects of THC and CBD, and how cannabis may influence various conditions.
Gamma irradiation leaves cannabinoid content largely intact and reduces terpene content. What the published evidence shows, and what it does not.
Motagon publishes articles on scientific findings, evidence, and practical realities of medical cannabis for patients and healthcare professionals.
How the endocannabinoid system works, what THC and CBD do, and why cannabis can affect such different conditions.
Motagon becomes the exclusive Czech distributor for Curaleaf medical cannabis products.
As of April 1, 2025, general practitioners with specialties 001 and 002 can prescribe for diagnosis R52.1.
From 1 April 2025, general practitioners with specialities 001 and 002 may prescribe for diagnosis R52.1.
July 2026: Motagon expands its EU-GMP Part II license, held since 2022, to include Part I for finished medicinal products.
July 2026, Motagon adds EU-GMP Part I for finished medicinal products to the Part II authorisation held since 2022.
Company announcements from Motagon and press coverage of the company.
Motagon distributes the Mota brand, distributes third-party medical cannabis brands, and provides EU-GMP Part I and Part II testing and release services.
Motagon s.r.o. is a Czech pharmaceutical company sourcing medical cannabis worldwide, releasing it under EU-GMP Part I and Part II, and distributing in Czechia and Poland.
Motagon s.r.o. is a Czech pharmaceutical company that sources medical cannabis globally, releases it under EU-GMP Part I and II, and distributes in the Czech Republic and Poland.
Motagon sells medical cannabis into Czechia and Poland, with an established route into a further 15 European markets through Heaton's distributor network.
Motagon's founding partners KOMAND Consulting and Jelinda, supply partner Curaleaf, and distribution partners Heaton and PHARMOS.
Motagon distributes the Mota brand, third-party medical cannabis brands, and provides EU-GMP Part I and II testing and release services.
Pharmacies can register with Motagon to receive batch release updates and be listed in the patient pharmacy finder.
Contact Motagon s.r.o. in Prague. Enquiries routed by audience: pharmacies and wholesalers, prescribers, producers and suppliers, patients and media.
Find a Czech pharmacy stocking Motagon medical cannabis products or able to order them via prescription.
The page describes how Czech pharmacies order Motagon medical cannabis products through distributors, how to become a partner pharmacy, and receive email alerts for each batch.
Contact Motagon s.r.o. in Prague for inquiries directed to pharmacies, distributors, doctors, manufacturers, suppliers, patients, and media.
Motagon distributes its own Mota brand and third-party medical cannabis brands in Czechia and Poland, and provides EU-GMP Part I and Part II testing and release for producers entering Europe.
Motagon distributes the Mota brand and third-party brands in the Czech Republic and Poland, and offers EU-GMP testing and release (Part I and II) for manufacturers targeting Europe.
The terms on which this website is provided.